Muscle News and Research RSS Feed - Muscle News and Research

New opioid use among older adults with COPD linked to increased risk for respiratory-related death

New opioid use among older adults with COPD linked to increased risk for respiratory-related death

Older adults with chronic obstructive pulmonary disease who start using opioids have a more than two-fold higher risk of dying from a respiratory-related complication compared to non-opioid users, St. Michael's Hospital researchers have found. [More]
Researchers study how skin stem cells respond to forces

Researchers study how skin stem cells respond to forces

All cells share the same genetic code, no matter if they are skin or brain cells. However, these cells are exposed to very different types of mechanical environments and mechanical stresses. [More]
Researchers identify PKD1 protein as potential cause for impaired insulin signaling in diabetics

Researchers identify PKD1 protein as potential cause for impaired insulin signaling in diabetics

Medication can help trigger the enzyme that kick starts insulin production in the body, but the drugs don't always work for those who are obese or diabetic, and most need to regulate their glucose and insulin levels. That's why a recent discovery made by Rudy Valentine and a team of researchers holds so much promise. [More]
Lifting lighter weights many times can be effective alternative way to gain muscle strength

Lifting lighter weights many times can be effective alternative way to gain muscle strength

New research from McMaster University is challenging traditional workout wisdom, suggesting that lifting lighter weights many times is as efficient as lifting heavy weights for fewer repetitions. [More]
New electronic tattoo can measure activity of muscle and nerve cells

New electronic tattoo can measure activity of muscle and nerve cells

A new temporary "electronic tattoo" developed by Tel Aviv University that can measure the activity of muscle and nerve cells researchers is poised to revolutionize medicine, rehabilitation, and even business and marketing research. [More]
Urolithin A found in pomegranates may improve muscle strength and endurance during aging

Urolithin A found in pomegranates may improve muscle strength and endurance during aging

Amazentis SA, an innovative life sciences company applying scientific breakthroughs in nutrition to manage health conditions linked to aging, announced today a collaborative publication in Nature Medicine with the École Polytechnique Fédérale de Lausanne, demonstrating that the Company's lead product candidate, urolithin A, improves mitochondrial and muscle function, resulting in enhanced muscle strength and endurance during aging. [More]
Non-drug solutions for postpartum depression: an interview with Dr David Brock & Christopher Thatcher

Non-drug solutions for postpartum depression: an interview with Dr David Brock & Christopher Thatcher

Postpartum depression (PPD) is reported to occur in 10-15% of delivering women with an estimated 400,000 women affected annually in the US. It is the most common complication of childbirth and is a significant public health concern. [More]
AAN, ABF and MDA offer new two-year clinical training fellowship in muscular dystrophy

AAN, ABF and MDA offer new two-year clinical training fellowship in muscular dystrophy

The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017. [More]
BetterYou’s transdermal MagnesiumOil Spray trio certified on Informed-Sport programme

BetterYou’s transdermal MagnesiumOil Spray trio certified on Informed-Sport programme

A transdermal trio of MagnesiumOil Sprays by health pioneers BetterYou has been certified for inclusion in the kit bags of the world’s elite sporting stars and coaches. [More]
UCI researchers use new imaging method to measure fat metabolism

UCI researchers use new imaging method to measure fat metabolism

A team from the University of California, Irvine and supported by the National Institute of Biomedical Imaging and Bioengineering has used a new imaging technique to measure how people break down dietary fat into products the cells of their bodies can use. [More]
Study identifies genetic mutations responsible for development of cardiac hypertrophy in adults

Study identifies genetic mutations responsible for development of cardiac hypertrophy in adults

Investigators at Beth Israel Deaconess Medical Center have identified a developmental cause of adult-onset cardiac hypertrophy, a dangerous thickening of the heart muscle that can lead to heart failure and death. [More]
Pediatric health educator provides tips for protecting children from heat stroke

Pediatric health educator provides tips for protecting children from heat stroke

Hot temperatures and high humidity can put nearly anyone at risk for dehydration and heat stroke, but children are especially vulnerable. [More]
Study shows twice daily exercise intervention improves bone strength in VLBW pre-term infants

Study shows twice daily exercise intervention improves bone strength in VLBW pre-term infants

Because of their low weight and premature birth, very low birth weight (VLBW) pre-term infants have lower bone mineral mass and a greater need for bone nutrients compared to most new-born infants. [More]
Bacterial infection may play role in causing OAB symptoms

Bacterial infection may play role in causing OAB symptoms

A team led by researchers at the University of Kent has identified bacterial infection as a possible cause of Overactive Bladder Syndrome (OAB). [More]
New genetic test provides rapid diagnosis of mitochondrial disease

New genetic test provides rapid diagnosis of mitochondrial disease

Newcastle researchers have developed a genetic test providing a rapid diagnosis of mitochondrial disorders to identify the first patients with inherited mutations in a new disease gene. [More]
Study underscores importance of targeting prevention efforts at preclinical HF stages

Study underscores importance of targeting prevention efforts at preclinical HF stages

According to a recent study of Framingham Study participants, nearly 60 percent of people have prevalent preclinical heart failure (HF) stages A and B. Heart failure occurs when the heart muscle is weakened and cannot pump enough blood to meet the body's needs for blood and oxygen. [More]
Diabetes drug metformin could help reduce toxic acid levels linked to MSUD

Diabetes drug metformin could help reduce toxic acid levels linked to MSUD

Maple Syrup Urine Disease (MSUD) is a rare inherited metabolic disorder involving the dysfunction of an enzyme which breaks down three essential amino acids: leucine, isoleucine and valine. [More]
New research reveals b1-integrin protein as promising therapeutic target for muscle aging

New research reveals b1-integrin protein as promising therapeutic target for muscle aging

As we age, the function and regenerative abilities of skeletal muscles deteriorate, which means it is difficult for the elderly to recover from injury or surgery. New work from Carnegie's Michelle Rozo, Liangji Li, and Chen-Ming Fan demonstrates that a protein called b1-integrin is crucial for muscle regeneration. [More]
European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Amgen has announced that the European Commission (EC) has approved a variation to the marketing authorization for Kyprolis® (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least one prior therapy. The extended indication marks the second approval for Kyprolis by the EC in less than a year. [More]
Alnylam reports new results from investigational RNAi therapeutic programs

Alnylam reports new results from investigational RNAi therapeutic programs

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today preliminary results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, both investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of hereditary TTR-mediated amyloidosis (hATTR amyloidosis). [More]
Advertisement
Advertisement